Actualités et vidéos - TESARO INC.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline - TSRO PR Newswire NEW YORK, Dec. 21, 2018 NEW YORK , Dec. 21, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO) and certain of its officers. The class action, filed in United States District Court, District of Massachusetts , and indexed under...

SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of Tesaro, Inc. - TSRO PR Newswire NEW YORK, Dec. 4, 2018 NEW YORK , Dec. 4, 2018 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating the Board of Directors and Officers of Tesaro, Inc. ("Tesaro" or the "Company") (NasdaqGS: TSRO) for...

NEW YORK, April 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MPLX LP (NYSE:MPLX), TESARO, Inc. (NASDAQ:TSRO), LKQ Corporation (NASDAQ:LKQ), Cytokinetics, Incorporated (NASDAQ:CYTK), Keysight Technologies Inc. (NYSE:KEYS), and Charles River Laboratories International, Inc. (NYSE:CRL), including updated fundamental summaries, consolidated...

TESARO LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Tesaro Incorporated To Contact The Firm PR Newswire NEW YORK, March 9, 2018 NEW YORK , March 9, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tesaro Incorporated ("Tesaro" or the "Company") (NASDAQ: TSRO) of the March 19, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed...

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / TESARO, Inc. (NASDAQ: TSRO ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 4:15 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/23004 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor Network Investor...

EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. - TSRO PR Newswire NEW YORK, Feb. 23, 2018 NEW YORK , Feb. 23, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TESARO, Inc. (NASDAQ: TSRO) from March 14, 2016 through January 12, 2018 , inclusive (the "Class Period"). The lawsuit seeks to recover damages for TESARO investors under...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline - TSRO PR Newswire NEW YORK, Feb. 17, 2018 NEW YORK , Feb. 17, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro Incorporated ("Tesaro" or the "Company") (NASDAQ: TSRO) and certain of its officers. The class action, filed in United States District Court, for the District of...

NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of TESARO, Inc. (NASDAQ:TSRO), Brunswick Corporation (NYSE:BC), Brooks Automation, Inc. (NASDAQ:BRKS), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Edison International (NYSE:EIX), and Anthem, Inc. (NYSE:ANTM), including updated fundamental summaries, consolidated fiscal reporting,...

Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Filed Against Tesaro, Inc. - TSRO PR Newswire RADNOR, Pa., Feb. 1, 2018 RADNOR, Pa. , Feb. 1, 2018 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against TESARO, Inc. (Nasdaq: TSRO) ("TESARO" or the "Company") on behalf of purchasers of the Company's securities between March 14, 2016 and January 12, 2018 , inclusive (the "Class Period")....

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018 PR Newswire NEW YORK, Jan. 19, 2018 NEW YORK , Jan. 19, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO) and certain of its officers, on behalf of shareholders who purchased Tesaro...

TESARO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Tesaro, Inc. To Contact The Firm PR Newswire NEW YORK, Jan. 17, 2018 NEW YORK , Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ:TSRO). If you invested in Tesaro stock or options and would like to discuss your legal rights, click here :...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Tesaro, Inc. (TSRO) PR Newswire NEW YORK, Jan. 16, 2018 NEW YORK , Jan. 16, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO) . Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/tsro ....

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tesaro, Inc. - TSRO PR Newswire NEW YORK, Jan. 16, 2018 NEW YORK , Jan. 16, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether Tesaro and certain of its officers and/or...

OncoQuest Announces Collaboration with TESARO in Recurrent Ovarian Cancer Setting PR Newswire EDMONTON, Oct. 26, 2017 Oregovomab to be Combined with ZEJULA ® in a Proof-of-Concept Clinical Study EDMONTON , Oct. 26, 2017 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical company focused on the development and commercialization of immunotherapeutic products for the treatment of cancer, today announced the signing of a collaborative agreement with TESARO, Inc. ("TESARO") to conduct a...

MIAMI, Oct. 26, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) announces that its licensee, TESARO, Inc. (Nasdaq:TSRO), received U.S. Food and Drug Administration (FDA) approval for VARUBI® (rolapitant) IV in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. Delayed nausea and vomiting can occur...

NEW YORK, NY / ACCESSWIRE / August 8, 2017 / TESARO, Inc. (NASDAQ: TSRO ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, 2017 at 4:15 PM Eastern Time. To listen to the event live - visit https://www.investornetwork.com/company/23004 . Replay Information The replay will be available online at https://www.investornetwork.com/company/23004 . About Investor Network Investor Network (IN) is a new financial content community, serving millions of...

NEW YORK, NY / ACCESSWIRE / May 9, 2017 / TESARO, Inc. (NASDAQ: TSRO ) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 4:15 PM Eastern Time. To listen to the event live – visit https://www.investornetwork.com/company/23004 . Replay Information The replay will be available online at https://www.investornetwork.com/company/23004 . About Investor Network Investor Network (IN) is a new financial content community, serving millions of unique investors...

TESARO Announces U.S. FDA Approval Of ZEJULA™ (Niraparib) For Women With Recurrent Ovarian Cancer - ZEJULA is the first and only PARP inhibitor to be approved for the maintenance treatment of women with recurrent ovarian cancer - Use of ZEJULA does not require patient selection with a biomarker test - U.S. commercial launch planned for late April - Investor conference call and webcast to be held at 4:30 PM ET today PR Newswire WALTHAM, Mass., March 27, 2017 WALTHAM, Mass. , March 27, 2017...

Learn how to target a 58% return on AveXis Inc., or get option-trade ideas on Ionis Pharmaceuticals, The Medicines Co, Prothena and Tesaro Inc. or any stock you choose PR Newswire CHICAGO, March 3, 2017 CHICAGO , March 3, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVXS, IONS, MDCO, PRTA, and TSRO. To see the high-return covered-call trades uncovered by InvestorsObserver's analysts, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding...

VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......